Archive for Category: General

Showing 81 – 90 of 104 results

  • New Technique to Derive Naive Pluripotent Stem Cells from Human Embryos

    Researchers from the University of Cambridge have come up with a technique using which naive pluripotent stem cells from human embryos can be derived. These cells are having amazing feature that they can develop into all human tissue other than placenta. The promising technique could open new gateways for research into disorders like Down’s syndrome. The researchers are quite hopeful that the development could lead to advances in regenerative medicine. To read more, please click here.
    Read More
  • PELOBiotech: Welcome, Katja!

    We are happy to announce that we enlarge our team and can serve you now even better. Katja Schulze joined our company in March and will be in charge of all customer questions in Germany and Switzerland. So go ahead and give her a call. 0049- 89- 517 286 59-0. She will be more than happy to be at your service.
    Read More
  • “Mini-Stomachs” That Produce Insulin When Transplanted

    A team of researchers have succeeded in creating mini insulin-producing organs that can be implanted into a diabetic animal to maintain glucose levels, progress towards what they consider the future of regenerative medicine. The cells the researchers found are best at producing insulin when reprogrammed are pylotic cells — cells from the lower region of the stomach, called the “pylorus region.” They think that these cells work best because they are naturally very similar to the pancreatic...
    Read More
  • In Vivo: New Modeling System for Disease Development

    Whitehead Institute researchers have created a new mouse-human modeling platform that could be used to study neural crest development as well as the modeling of a variety of diseases, including such cancers as melanoma and neurofibromatosis. “We introduced human committed stem cells at the right stage into the mouse embryo in utero and had them integrate into developing tissues,” says Whitehead Founding Member Rudolf Jaenisch. “The results are encouraging and provide a proof of principle...
    Read More
  • PELOBIOTECH: Welcome our New Partner SynVivo

    Our new partner SynVivo is based in Houston, Texas, USA. SynVivo has developed microfluidics-based chips. These cell based assays provide morphologically and biologically realistic microenviroments and allow real-time study of cellular behavior, drug delivery and drug discovery – fast and cost effective, for industry and pharma research. Basic applications are f.ex: • Inflammation (leukocyte-endothelium) • Cancer (tumor-endothelium) • Thrombosis (platelet-endothelium) • Infection...
    Read More
  • Flu May Hit Men Harder than Women: Here’s Why

    A new study that highlights the antiviral effects of the female hormone estrogen, could lead to novel flu therapies. By isolating estrogen from female patients, researchers found that it can protect against the influenza A virus. The study was conducted by researchers from John Hopkins University, and is published in American Journal of Physiology—Lung Cellular and Molecular Physiology. To read more, please click here.
    Read More
  • Skin Cells can Heal Injured Hearts

    Usually after a heart attack, the heart is unable to replace its dead cells and patients are often left with little option of another heart transplant or cell therapy that transplants heart cells into the patient’s heart. Dr. Shunsuke Funakoshi (Kyoto University) took induced pluripotent stem (iPS) cells that were reprogrammed from skin cellsduring the research, and made them into heart cells. To read more about Funakoshi’s research, please click here.
    Read More
  • Kinetics of circulating EPCs

    Endothelial progenitor cells (EPCs) are primitive cells found in the bone marrow and peripheral blood (PB). In particular, the potential of EPCs to differentiate into mature endothelial cells remains of high interest for clinical applications such as bio-functionalized patches for autologous seeding after implantation. The objective of this study was to determine EPCs’ kinetics in patients undergoing carotid artery thromboendarterectomy (CTEA) and patch angioplasty. Methods: Twenty CTEA patients...
    Read More
  • Study: Stem Cells likely to be Safe for Use in Regenerative Medicine

    Cambridge researchers have found the strongest evidence to date that human pluripotent stem cells – cells that can give rise to all tissues of the body – will develop normally once transplanted into an embryo. The findings, published in the journal Cell Stem Cell, could have important implications for regenerative medicine. See more here.
    Read More
  • New Southafrican Supplier at PELOBiotech – ReSyn Biosciences

    We are happy to welcome ReSyn Biosciences as a new member of the PELOBiotech family. The South-African start-up  is specialized  in high-performance high capacity magnetic microsphere products, the MagReSyn® range. PELOBiotech is now exclusive distributor of the MagReSyn® product line in Germany and Switzerland. ReSyn Biosciences was awarded  with the New Product Award (NPA) at the Society for Lab Automation and Screening (SLAS) conference and exhibition 2015 in Washington DC, USA. The high-performance...
    Read More